Characterisation of tyrosine kinase inhibitor-receptor interactions at VEGFR2 using sunitinib-red and nanoBRET. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bcp.2023.115672
PubMed Identifier: 37406966
Publication URI: http://europepmc.org/abstract/MED/37406966
Type: Journal Article/Review
Volume: 214
Parent Publication: Biochemical pharmacology
ISSN: 0006-2952